Quantification of pAMPKThr172-positive epifluorescence confirmed increased AMPK activity in RGC from glaucoma patients (Fig. 2O, n = 100 RGC/human retinal specimen, Student’s t-test, p < 0.001, see Methods). This evidence concerns the gene PRKAA1 and glaucoma.